ID   SYHC_HUMAN              Reviewed;         509 AA.
AC   P12081; B4DHQ1; B4DY73; D6REN6; J3KNE5;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 2.
DT   10-MAY-2017, entry version 185.
DE   RecName: Full=Histidine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.21;
DE   AltName: Full=Histidyl-tRNA synthetase;
DE            Short=HisRS;
GN   Name=HARS; Synonyms=HRS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1549469; DOI=10.1093/nar/20.5.1075;
RA   Raben N., Borriello F., Amin J., Horwitz R., Fraser D., Plotz P.;
RT   "Human histidyl-tRNA synthetase: recognition of amino acid signature
RT   regions in class 2a aminoacyl-tRNA synthetases.";
RL   Nucleic Acids Res. 20:1075-1081(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3554142; DOI=10.1093/nar/15.8.3349;
RA   Tsui F.W.L., Siminovitch L.;
RT   "Isolation, structure and expression of mammalian genes for histidyl-
RT   tRNA synthetase.";
RL   Nucleic Acids Res. 15:3349-3367(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Caudate nucleus, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-30.
RX   PubMed=8406012; DOI=10.1016/0378-1119(93)90294-D;
RA   Tsui H.W., Mok S., de Souza L., Martin A., Tsui F.W.L.;
RT   "Transcriptional analyses of the gene region that encodes human
RT   histidyl-tRNA synthetase: identification of a novel bidirectional
RT   regulatory element.";
RL   Gene 131:201-208(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-30.
RX   PubMed=7755634; DOI=10.1006/bbrc.1995.1696;
RA   O'Hanlon T.P., Raben N., Miller F.W.;
RT   "A novel gene oriented in a head-to-head configuration with the human
RT   histidyl-tRNA synthetase (HRS) gene encodes an mRNA that predicts a
RT   polypeptide homologous to HRS.";
RL   Biochem. Biophys. Res. Commun. 210:556-566(1995).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INVOLVEMENT IN CMT2W, VARIANTS GLU-5; ASP-205 AND ARG-376, VARIANTS
RP   CMT2W GLN-137; ALA-238 AND SER-505, AND CHARACTERIZATION OF VARIANT
RP   CMT2W GLN-137.
RX   PubMed=22930593; DOI=10.1002/humu.22210;
RG   NISC comparative sequencing program;
RA   Vester A., Velez-Ruiz G., McLaughlin H.M., Lupski J.R., Talbot K.,
RA   Vance J.M., Zuchner S., Roda R.H., Fischbeck K.H., Biesecker L.G.,
RA   Nicholson G., Beg A.A., Antonellis A.;
RT   "A loss-of-function variant in the human histidyl-tRNA synthetase
RT   (HARS) gene is neurotoxic in vivo.";
RL   Hum. Mutat. 34:191-199(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   FUNCTION, INVOLVEMENT IN CMT2W, VARIANTS CMT2W ILE-132; HIS-134;
RP   GLU-175 AND TYR-364, AND CHARACTERIZATION OF VARIANTS CMT2W ILE-132;
RP   HIS-134; GLU-175 AND TYR-364.
RX   PubMed=26072516; DOI=10.1093/brain/awv158;
RA   Safka Brozkova D., Deconinck T., Griffin L.B., Ferbert A.,
RA   Haberlova J., Mazanec R., Lassuthova P., Roth C., Pilunthanakul T.,
RA   Rautenstrauss B., Janecke A.R., Zavadakova P., Chrast R., Rivolta C.,
RA   Zuchner S., Antonellis A., Beg A.A., De Jonghe P., Senderek J.,
RA   Seeman P., Baets J.;
RT   "Loss of function mutations in HARS cause a spectrum of inherited
RT   peripheral neuropathies.";
RL   Brain 138:2161-2172(2015).
RN   [14]
RP   STRUCTURE BY NMR OF 1-60.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the WHEP-TRS domain of human histidyl-tRNA
RT   synthetase.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [15]
RP   VARIANT USH3B SER-454.
RX   PubMed=22279524; DOI=10.1371/journal.pone.0028936;
RA   Puffenberger E.G., Jinks R.N., Sougnez C., Cibulskis K., Willert R.A.,
RA   Achilly N.P., Cassidy R.P., Fiorentini C.J., Heiken K.F.,
RA   Lawrence J.J., Mahoney M.H., Miller C.J., Nair D.T., Politi K.A.,
RA   Worcester K.N., Setton R.A., Dipiazza R., Sherman E.A., Eastman J.T.,
RA   Francklyn C., Robey-Bond S., Rider N.L., Gabriel S., Morton D.H.,
RA   Strauss K.A.;
RT   "Genetic mapping and exome sequencing identify variants associated
RT   with five novel diseases.";
RL   PLoS ONE 7:E28936-E28936(2012).
CC   -!- FUNCTION: Cytoplasmic histidine--tRNA ligase (Probable). Plays a
CC       role in axon guidance. {ECO:0000269|PubMed:26072516, ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-histidine + tRNA(His) = AMP +
CC       diphosphate + L-histidyl-tRNA(His).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P12081-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P12081-2; Sequence=VSP_045118;
CC       Name=3;
CC         IsoId=P12081-3; Sequence=VSP_045118, VSP_046662;
CC       Name=4;
CC         IsoId=P12081-4; Sequence=VSP_046662;
CC   -!- TISSUE SPECIFICITY: Brain, heart, liver and kidney.
CC   -!- DISEASE: Usher syndrome 3B (USH3B) [MIM:614504]: A syndrome
CC       characterized by progressive vision and hearing loss during early
CC       childhood. Some patients have the so-called 'Charles Bonnet
CC       syndrome,' involving decreased visual acuity and vivid visual
CC       hallucinations. USH is a genetically heterogeneous condition
CC       characterized by the association of retinitis pigmentosa with
CC       sensorineural deafness. Age at onset and differences in auditory
CC       and vestibular function distinguish Usher syndrome type 1 (USH1),
CC       Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3).
CC       USH3 is characterized by postlingual, progressive hearing loss,
CC       variable vestibular dysfunction, and onset of retinitis pigmentosa
CC       symptoms, including nyctalopia, constriction of the visual fields,
CC       and loss of central visual acuity, usually by the second decade of
CC       life. {ECO:0000269|PubMed:22279524}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2W (CMT2W) [MIM:616625]: An
CC       autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a
CC       disorder of the peripheral nervous system, characterized by
CC       progressive weakness and atrophy, initially of the peroneal
CC       muscles and later of the distal muscles of the arms. Charcot-
CC       Marie-Tooth disease is classified in two main groups on the basis
CC       of electrophysiologic properties and histopathology: primary
CC       peripheral demyelinating neuropathies (designated CMT1 when they
CC       are dominantly inherited) and primary peripheral axonal
CC       neuropathies (CMT2). Neuropathies of the CMT2 group are
CC       characterized by signs of axonal degeneration in the absence of
CC       obvious myelin alterations, normal or slightly reduced nerve
CC       conduction velocities, and progressive distal muscle weakness and
CC       atrophy. CMT2W patients manifest a peripheral neuropathy mainly
CC       affecting the lower limbs and resulting in gait difficulties and
CC       distal sensory impairment. Most patients also have upper limb
CC       involvement. {ECO:0000269|PubMed:22930593,
CC       ECO:0000269|PubMed:26072516}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA28956.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11518; CAA77607.1; -; mRNA.
DR   EMBL; X05345; CAA28956.1; ALT_FRAME; mRNA.
DR   EMBL; AK295219; BAG58213.1; -; mRNA.
DR   EMBL; AK302295; BAG63635.1; -; mRNA.
DR   EMBL; AK225776; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC116353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011807; AAH11807.1; -; mRNA.
DR   EMBL; BC080514; AAH80514.1; -; mRNA.
DR   EMBL; M96646; AAA58668.1; -; Genomic_DNA.
DR   EMBL; U18936; AAA73973.1; -; Genomic_DNA.
DR   CCDS; CCDS4237.1; -. [P12081-1]
DR   CCDS; CCDS58976.1; -. [P12081-2]
DR   CCDS; CCDS58977.1; -. [P12081-3]
DR   CCDS; CCDS58978.1; -. [P12081-4]
DR   PIR; I37559; SYHUHT.
DR   RefSeq; NP_001244969.1; NM_001258040.2. [P12081-2]
DR   RefSeq; NP_001244970.1; NM_001258041.2. [P12081-4]
DR   RefSeq; NP_001244971.1; NM_001258042.2. [P12081-3]
DR   RefSeq; NP_002100.2; NM_002109.5. [P12081-1]
DR   UniGene; Hs.528050; -.
DR   PDB; 1X59; NMR; -; A=1-60.
DR   PDB; 2LW7; NMR; -; A=2-509.
DR   PDB; 4G84; X-ray; 2.40 A; A/B=54-506.
DR   PDB; 4G85; X-ray; 3.11 A; A/B=1-506.
DR   PDB; 4PHC; X-ray; 2.84 A; A/B/C/D=1-509.
DR   PDB; 4X5O; X-ray; 2.80 A; A/B=1-509.
DR   PDBsum; 1X59; -.
DR   PDBsum; 2LW7; -.
DR   PDBsum; 4G84; -.
DR   PDBsum; 4G85; -.
DR   PDBsum; 4PHC; -.
DR   PDBsum; 4X5O; -.
DR   ProteinModelPortal; P12081; -.
DR   SMR; P12081; -.
DR   BioGrid; 109285; 48.
DR   DIP; DIP-37596N; -.
DR   IntAct; P12081; 3.
DR   MINT; MINT-3007818; -.
DR   STRING; 9606.ENSP00000425634; -.
DR   BindingDB; P12081; -.
DR   ChEMBL; CHEMBL4002; -.
DR   DrugBank; DB00117; L-Histidine.
DR   iPTMnet; P12081; -.
DR   PhosphoSitePlus; P12081; -.
DR   SwissPalm; P12081; -.
DR   BioMuta; HARS; -.
DR   DMDM; 135123; -.
DR   EPD; P12081; -.
DR   MaxQB; P12081; -.
DR   PaxDb; P12081; -.
DR   PeptideAtlas; P12081; -.
DR   PRIDE; P12081; -.
DR   Ensembl; ENST00000307633; ENSP00000304668; ENSG00000170445. [P12081-3]
DR   Ensembl; ENST00000438307; ENSP00000411511; ENSG00000170445. [P12081-2]
DR   Ensembl; ENST00000457527; ENSP00000387893; ENSG00000170445. [P12081-4]
DR   Ensembl; ENST00000504156; ENSP00000425634; ENSG00000170445. [P12081-1]
DR   GeneID; 3035; -.
DR   KEGG; hsa:3035; -.
DR   UCSC; uc003lgv.6; human. [P12081-1]
DR   CTD; 3035; -.
DR   DisGeNET; 3035; -.
DR   GeneCards; HARS; -.
DR   HGNC; HGNC:4816; HARS.
DR   HPA; HPA036539; -.
DR   MalaCards; HARS; -.
DR   MIM; 142810; gene.
DR   MIM; 614504; phenotype.
DR   MIM; 616625; phenotype.
DR   neXtProt; NX_P12081; -.
DR   OpenTargets; ENSG00000170445; -.
DR   Orphanet; 231183; Usher syndrome type 3.
DR   PharmGKB; PA29191; -.
DR   eggNOG; KOG1936; Eukaryota.
DR   eggNOG; COG0124; LUCA.
DR   GeneTree; ENSGT00390000005922; -.
DR   HOGENOM; HOG000018075; -.
DR   HOVERGEN; HBG002731; -.
DR   InParanoid; P12081; -.
DR   KO; K01892; -.
DR   OMA; TRDYGPQ; -.
DR   OrthoDB; EOG091G05P3; -.
DR   PhylomeDB; P12081; -.
DR   TreeFam; TF300652; -.
DR   BRENDA; 6.1.1.21; 2681.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; HARS; human.
DR   EvolutionaryTrace; P12081; -.
DR   GeneWiki; HARS; -.
DR   GenomeRNAi; 3035; -.
DR   PRO; PR:P12081; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170445; -.
DR   CleanEx; HS_HARS; -.
DR   ExpressionAtlas; P12081; baseline and differential.
DR   Genevisible; P12081; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004821; F:histidine-tRNA ligase activity; TAS:Reactome.
DR   GO; GO:0006427; P:histidyl-tRNA aminoacylation; IEA:InterPro.
DR   GO; GO:0032543; P:mitochondrial translation; IBA:GO_Central.
DR   GO; GO:0006412; P:translation; NAS:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00859; HisRS_anticodon; 1.
DR   Gene3D; 3.40.50.800; -; 1.
DR   HAMAP; MF_00127; His_tRNA_synth; 1.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR015807; His-tRNA-ligase.
DR   InterPro; IPR004516; HisRS/HisZ.
DR   InterPro; IPR033656; HisRS_anticodon.
DR   InterPro; IPR009068; S15_NS1_RNA-bd.
DR   InterPro; IPR000738; WHEP-TRS_dom.
DR   PANTHER; PTHR11476; PTHR11476; 1.
DR   Pfam; PF03129; HGTP_anticodon; 1.
DR   Pfam; PF00458; WHEP-TRS; 1.
DR   PIRSF; PIRSF001549; His-tRNA_synth; 1.
DR   SMART; SM00991; WHEP-TRS; 1.
DR   SUPFAM; SSF47060; SSF47060; 1.
DR   SUPFAM; SSF52954; SSF52954; 1.
DR   TIGRFAMs; TIGR00442; hisS; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
DR   PROSITE; PS00762; WHEP_TRS_1; 1.
DR   PROSITE; PS51185; WHEP_TRS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Charcot-Marie-Tooth disease;
KW   Complete proteome; Cytoplasm; Deafness; Disease mutation; Ligase;
KW   Neurodegeneration; Neuropathy; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein biosynthesis; Reference proteome;
KW   Retinitis pigmentosa; Usher syndrome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    509       Histidine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000136332.
FT   DOMAIN        3     59       WHEP-TRS.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      60     99       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045118.
FT   VAR_SEQ     155    174       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_046662.
FT   VARIANT       5      5       A -> E (in dbSNP:rs78741041).
FT                                {ECO:0000269|PubMed:22930593}.
FT                                /FTId=VAR_069021.
FT   VARIANT     132    132       T -> I (in CMT2W; loss-of-function
FT                                mutation; dbSNP:rs143473232).
FT                                {ECO:0000269|PubMed:26072516}.
FT                                /FTId=VAR_075064.
FT   VARIANT     134    134       P -> H (in CMT2W; loss-of-function
FT                                mutation; dbSNP:rs863225122).
FT                                {ECO:0000269|PubMed:26072516}.
FT                                /FTId=VAR_075065.
FT   VARIANT     137    137       R -> Q (in CMT2W; has a neurotoxic effect
FT                                in an animal model; results in loss of
FT                                function; dbSNP:rs191391414).
FT                                {ECO:0000269|PubMed:22930593}.
FT                                /FTId=VAR_069022.
FT   VARIANT     175    175       D -> E (in CMT2W; hypomorphic mutation;
FT                                dbSNP:rs863225123).
FT                                {ECO:0000269|PubMed:26072516}.
FT                                /FTId=VAR_075066.
FT   VARIANT     205    205       G -> D (in dbSNP:rs147288996).
FT                                {ECO:0000269|PubMed:22930593}.
FT                                /FTId=VAR_069023.
FT   VARIANT     238    238       V -> A (in CMT2W; unknown pathological
FT                                significance; dbSNP:rs536175170).
FT                                {ECO:0000269|PubMed:22930593}.
FT                                /FTId=VAR_069024.
FT   VARIANT     364    364       D -> Y (in CMT2W; loss-of-function
FT                                mutation; dbSNP:rs863225124).
FT                                {ECO:0000269|PubMed:26072516}.
FT                                /FTId=VAR_075067.
FT   VARIANT     376    376       K -> R (in dbSNP:rs139447495).
FT                                {ECO:0000269|PubMed:22930593}.
FT                                /FTId=VAR_069025.
FT   VARIANT     399    399       A -> V (in dbSNP:rs34732372).
FT                                /FTId=VAR_061908.
FT   VARIANT     454    454       Y -> S (in USH3B; dbSNP:rs387906639).
FT                                {ECO:0000269|PubMed:22279524}.
FT                                /FTId=VAR_067918.
FT   VARIANT     505    505       P -> S (in CMT2W; unknown pathological
FT                                significance; dbSNP:rs747156884).
FT                                {ECO:0000269|PubMed:22930593}.
FT                                /FTId=VAR_069026.
FT   CONFLICT      6      6       A -> P (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    126    126       S -> P (in Ref. 3; BAG58213).
FT                                {ECO:0000305}.
FT   CONFLICT    165    165       R -> G (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       N -> Q (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       I -> N (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    191    191       C -> S (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    206    206       D -> N (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    223    223       I -> V (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    227    227       S -> P (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    284    284       L -> V (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       A -> E (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    373    374       KG -> QR (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   CONFLICT    375    375       R -> L (in Ref. 3; BAG58213).
FT                                {ECO:0000305}.
FT   CONFLICT    493    493       D -> E (in Ref. 2; CAA28956).
FT                                {ECO:0000305}.
FT   HELIX         2     23       {ECO:0000244|PDB:1X59}.
FT   HELIX        28     45       {ECO:0000244|PDB:1X59}.
FT   HELIX        67     86       {ECO:0000244|PDB:4G84}.
FT   STRAND       96     99       {ECO:0000244|PDB:4G84}.
FT   HELIX       100    103       {ECO:0000244|PDB:4G84}.
FT   TURN        104    106       {ECO:0000244|PDB:4PHC}.
FT   HELIX       109    113       {ECO:0000244|PDB:4PHC}.
FT   STRAND      120    122       {ECO:0000244|PDB:4X5O}.
FT   STRAND      125    127       {ECO:0000244|PDB:4G84}.
FT   HELIX       132    141       {ECO:0000244|PDB:4G84}.
FT   STRAND      147    156       {ECO:0000244|PDB:4G84}.
FT   STRAND      163    165       {ECO:0000244|PDB:4X5O}.
FT   STRAND      169    180       {ECO:0000244|PDB:4G84}.
FT   HELIX       186    202       {ECO:0000244|PDB:4G84}.
FT   STRAND      207    213       {ECO:0000244|PDB:4G84}.
FT   HELIX       214    224       {ECO:0000244|PDB:4G84}.
FT   HELIX       228    238       {ECO:0000244|PDB:4G84}.
FT   HELIX       239    242       {ECO:0000244|PDB:4G84}.
FT   HELIX       246    255       {ECO:0000244|PDB:4G84}.
FT   HELIX       261    271       {ECO:0000244|PDB:4G84}.
FT   STRAND      274    276       {ECO:0000244|PDB:4G84}.
FT   HELIX       277    283       {ECO:0000244|PDB:4G84}.
FT   HELIX       287    290       {ECO:0000244|PDB:4G84}.
FT   HELIX       293    311       {ECO:0000244|PDB:4G84}.
FT   HELIX       315    317       {ECO:0000244|PDB:4G84}.
FT   STRAND      318    321       {ECO:0000244|PDB:4G84}.
FT   TURN        328    330       {ECO:0000244|PDB:4G84}.
FT   STRAND      332    342       {ECO:0000244|PDB:4G84}.
FT   STRAND      352    362       {ECO:0000244|PDB:4G84}.
FT   HELIX       367    369       {ECO:0000244|PDB:4G84}.
FT   STRAND      371    373       {ECO:0000244|PDB:4G85}.
FT   STRAND      379    384       {ECO:0000244|PDB:4G84}.
FT   HELIX       386    398       {ECO:0000244|PDB:4G84}.
FT   TURN        399    401       {ECO:0000244|PDB:4G84}.
FT   STRAND      411    414       {ECO:0000244|PDB:4G84}.
FT   STRAND      416    419       {ECO:0000244|PDB:4G84}.
FT   HELIX       421    433       {ECO:0000244|PDB:4G84}.
FT   STRAND      438    440       {ECO:0000244|PDB:4G85}.
FT   STRAND      442    445       {ECO:0000244|PDB:4X5O}.
FT   HELIX       448    458       {ECO:0000244|PDB:4G84}.
FT   STRAND      462    465       {ECO:0000244|PDB:4G84}.
FT   HELIX       468    473       {ECO:0000244|PDB:4G84}.
FT   STRAND      475    480       {ECO:0000244|PDB:4G84}.
FT   TURN        481    483       {ECO:0000244|PDB:4G84}.
FT   STRAND      486    490       {ECO:0000244|PDB:4G84}.
FT   HELIX       491    493       {ECO:0000244|PDB:4G84}.
FT   HELIX       494    502       {ECO:0000244|PDB:4G84}.
SQ   SEQUENCE   509 AA;  57411 MW;  65D8BB71CE79B1FF CRC64;
     MAERAALEEL VKLQGERVRG LKQQKASAEL IEEEVAKLLK LKAQLGPDES KQKFVLKTPK
     GTRDYSPRQM AVREKVFDVI IRCFKRHGAE VIDTPVFELK ETLMGKYGED SKLIYDLKDQ
     GGELLSLRYD LTVPFARYLA MNKLTNIKRY HIAKVYRRDN PAMTRGRYRE FYQCDFDIAG
     NFDPMIPDAE CLKIMCEILS SLQIGDFLVK VNDRRILDGM FAICGVSDSK FRTICSSVDK
     LDKVSWEEVK NEMVGEKGLA PEVADRIGDY VQQHGGVSLV EQLLQDPKLS QNKQALEGLG
     DLKLLFEYLT LFGIDDKISF DLSLARGLDY YTGVIYEAVL LQTPAQAGEE PLGVGSVAAG
     GRYDGLVGMF DPKGRKVPCV GLSIGVERIF SIVEQRLEAL EEKIRTTETQ VLVASAQKKL
     LEERLKLVSE LWDAGIKAEL LYKKNPKLLN QLQYCEEAGI PLVAIIGEQE LKDGVIKLRS
     VTSREEVDVR REDLVEEIKR RTGQPLCIC
//
